Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis

Michael Centola, Z. Szekanecz, E. Kiss, M. Zeher, G. Szegedi, Britt Nakken, Peter Szodoray

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Gene expression profiling using microarray technology is being employed to define specific molecular mediators and pathways involved in immunobiology, to understand the intricate interplay of genes participating in the pathogenesis, and to develop biomarkers of disease activity in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review summarizes the latest information on the pathogenesis of SLE and RA and describes the utilization of microarray technology in these systemic autoimmune diseases.

Original languageEnglish
Pages (from-to)797-806
Number of pages10
JournalExpert Review of Clinical Immunology
Volume3
Issue number5
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Transcriptome
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Technology
Gene Expression Profiling
Autoimmune Diseases
Biomarkers
Genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis. / Centola, Michael; Szekanecz, Z.; Kiss, E.; Zeher, M.; Szegedi, G.; Nakken, Britt; Szodoray, Peter.

In: Expert Review of Clinical Immunology, Vol. 3, No. 5, 09.2007, p. 797-806.

Research output: Contribution to journalArticle

@article{af404dc82c4047e7beb4c93326e1a6d1,
title = "Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis",
abstract = "Gene expression profiling using microarray technology is being employed to define specific molecular mediators and pathways involved in immunobiology, to understand the intricate interplay of genes participating in the pathogenesis, and to develop biomarkers of disease activity in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review summarizes the latest information on the pathogenesis of SLE and RA and describes the utilization of microarray technology in these systemic autoimmune diseases.",
author = "Michael Centola and Z. Szekanecz and E. Kiss and M. Zeher and G. Szegedi and Britt Nakken and Peter Szodoray",
year = "2007",
month = "9",
doi = "10.1586/1744666X.3.5.797",
language = "English",
volume = "3",
pages = "797--806",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis

AU - Centola, Michael

AU - Szekanecz, Z.

AU - Kiss, E.

AU - Zeher, M.

AU - Szegedi, G.

AU - Nakken, Britt

AU - Szodoray, Peter

PY - 2007/9

Y1 - 2007/9

N2 - Gene expression profiling using microarray technology is being employed to define specific molecular mediators and pathways involved in immunobiology, to understand the intricate interplay of genes participating in the pathogenesis, and to develop biomarkers of disease activity in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review summarizes the latest information on the pathogenesis of SLE and RA and describes the utilization of microarray technology in these systemic autoimmune diseases.

AB - Gene expression profiling using microarray technology is being employed to define specific molecular mediators and pathways involved in immunobiology, to understand the intricate interplay of genes participating in the pathogenesis, and to develop biomarkers of disease activity in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review summarizes the latest information on the pathogenesis of SLE and RA and describes the utilization of microarray technology in these systemic autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=34648843553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648843553&partnerID=8YFLogxK

U2 - 10.1586/1744666X.3.5.797

DO - 10.1586/1744666X.3.5.797

M3 - Article

C2 - 20477029

AN - SCOPUS:34648843553

VL - 3

SP - 797

EP - 806

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 5

ER -